4-butyrolactone has been researched along with Thrombosis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
El-Fattah, MA; Khan, JA; Zohny, SF | 1 |
Chen, YS; Du, JR; He, Y; Wang, CY; Wang, J; Yu, DK; Zhang, L | 1 |
2 other study(ies) available for 4-butyrolactone and Thrombosis
Article | Year |
---|---|
Circulating Fibroblast Growth Factor-23 Level and Paraoxonase-1 Lactonase Activity in Chronic Hemodialysis Patients: Their Impact on the Incidence of Native AV Fistula Thrombosis.
Topics: 4-Butyrolactone; Adult; Aged; Arteriovenous Fistula; Aryldialkylphosphatase; Case-Control Studies; Enzyme-Linked Immunosorbent Assay; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Thrombosis | 2016 |
Z-ligustilide extracted from Radix Angelica Sinensis decreased platelet aggregation induced by ADP ex vivo and arterio-venous shunt thrombosis in vivo in rats.
Topics: 4-Butyrolactone; Adenosine Diphosphate; Angelica sinensis; Animals; Blood Coagulation; Depression, Chemical; Disease Models, Animal; Drugs, Chinese Herbal; Male; Platelet Aggregation; Rats; Rats, Sprague-Dawley; Thrombosis | 2009 |